Innovent Biologics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	17,102	7,456	8,030	6,168	7,955	12,136
Market Cap Growth	158.77%	-7.15%	30.17%	-22.46%	-34.45%	216.45%
Enterprise Value	16,369	6,750	7,395	5,388	6,693	11,531
Last Close Price	9.75	4.36	4.50	3.84	5.10	8.05
PS Ratio	12.60	5.98	10.14	9.98	13.46	25.21
PB Ratio	9.98	4.30	5.02	4.24	5.56	11.04
P/TBV Ratio	11.04	4.40	5.04	4.25	5.57	11.04
P/FCF Ratio	99.39	175.32	-	-	-	-
P/OCF Ratio	79.21	43.78	425.78	-	-	-
EV/Sales Ratio	12.04	5.41	9.34	8.72	11.33	23.96
EV/EBITDA Ratio	108.80	2126.28	-	-	-	-
EV/FCF Ratio	95.13	158.73	-	-	-	-
Debt / Equity Ratio	0.23	0.22	0.29	0.30	0.24	0.14
Debt / EBITDA Ratio	2.54	50.93	-	-	-	-
Debt / FCF Ratio	2.33	8.81	-	-	-	-
Net Debt / Equity Ratio	-0.43	-0.38	-0.59	-0.55	-0.63	-0.79
Net Debt / EBITDA Ratio	-4.73	-210.62	5.70	2.06	2.57	14.13
Net Debt / FCF Ratio	-4.26	-15.72	7.56	2.11	2.11	8.68
Asset Turnover	0.52	0.45	0.33	0.27	0.30	0.40
Inventory Turnover	2.94	2.69	1.51	1.00	1.19	1.45
Quick Ratio	2.25	2.08	2.68	2.78	3.27	5.85
Current Ratio	2.61	2.35	3.00	3.29	3.79	6.37
Return on Equity (ROE)	8.43%	-0.74%	-8.84%	-20.70%	-28.56%	-14.75%
Return on Assets (ROA)	2.65%	-0.82%	-5.12%	-11.54%	-12.04%	-3.65%
Return on Capital Employed (ROCE)	5.00%	-1.60%	-9.70%	-22.20%	-20.50%	-5.40%
Earnings Yield	0.79%	-0.17%	-1.63%	-4.79%	-4.75%	-1.03%
FCF Yield	1.01%	0.57%	-1.54%	-6.19%	-5.38%	-0.82%
Buyback Yield / Dilution	-3.74%	-4.35%	-4.67%	-2.37%	-7.27%	-15.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.